cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common StockNewsfile Corp • 05/01/23
cbdMD, Inc. Announces One-for-Forty Five Reverse Stock Split of Its Common StockNewsfile Corp • 04/14/23
cbdMD™ Makes History Becoming the First CBD Brand to Achieve 3 NSF's Certified for Sport® CertificationsBusiness Wire • 03/07/23
cbdMD to Present at NutraIngredients-USA's Sports and Active Nutrition SummitNewsfile Corp • 02/16/23
cbdMD Receives $1 Million Return of Capital Following Closing of Adara SPAC TransactionNewsfile Corp • 02/13/23
cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2023 ResultsNewsfile Corp • 02/06/23
cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent NewsNewsfile Corp • 01/26/23
cbdMD, Inc. to Host Conference Call to Discuss Fourth Quarter and Fiscal 2022 ResultsNewsfile Corp • 12/14/22
cbdMD to Present at ThinkEquity Conference on October 26, 2022, in New York CityNewsfile Corp • 10/25/22
cbdMD Delivers on its Promise of Operating Improvement, adds Regulatory Depth to the BoardNewsfile Corp • 08/11/22
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2022, Third Quarter ResultsNewsfile Corp • 08/08/22
cbdMD's Dr. Sibyl Swift Provides Testimony To the FDA Science Board on Proper Safety Methods for CBD ProductsNewsfile Corp • 06/29/22